Skip to content
PICO Portalanswers from OpenAlex

Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective

PaperCitations, authors & open-access status

Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective is a paper indexed in PICO Portal from OpenAlex.

How many citations does Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective have?

PICO Portalcitation count

Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective has 6 citations in the OpenAlex counts PICO Portal stores.

When was Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective published?

PICO Portalyear

Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective has 2024 year in the PICO Portal index.

What is the open-access status of Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective?

PICO Portaloa status

Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective has hybrid oa status in the PICO Portal index.

What is the DOI of Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective?

PICO Portaldoi

The DOI for Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective is on the source record.

What is the PMID of Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective?

PICO Portalpmid

The PMID for Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective is on the source record.

What is the OpenAlex record for Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective?

PICO Portalopenalex

The OpenAlex for Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial